MedPath
NMPA Approval

Methotrexate for Injection

国药准字H20045041

July 20, 2022

国药准字H20045041

Drug Information

注射用甲氨蝶呤

注射剂

5mg

化学药品

July 20, 2022

Company Information

Applicant Company

武汉东湖新技术开发区高新大道858号生物医药园

Manufacturing Company

湖北省武汉东湖新技术开发区高新大道858号生物医药园A1-1

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用甲氨蝶呤 - NMPA 批准文号 | MedPath